|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
HRP20220070T1
(hr)
|
2014-04-23 |
2022-04-01 |
Modernatx, Inc. |
Cjepiva nukleinske kiseline
|
|
US11364292B2
(en)
|
2015-07-21 |
2022-06-21 |
Modernatx, Inc. |
CHIKV RNA vaccines
|
|
MA42502A
(fr)
|
2015-07-21 |
2018-05-30 |
Modernatx Inc |
Vaccins contre une maladie infectieuse
|
|
EP3328394A4
(en)
|
2015-07-30 |
2019-03-13 |
ModernaTX, Inc. |
CONCATEMEE peptide epitope RNAs
|
|
WO2017031232A1
(en)
|
2015-08-17 |
2017-02-23 |
Modernatx, Inc. |
Methods for preparing particles and related compositions
|
|
DE20164728T1
(de)
|
2015-10-22 |
2021-09-30 |
Modernatx, Inc. |
Impfstoffe gegen atemwegsvirus
|
|
EP3364981A4
(en)
|
2015-10-22 |
2019-08-07 |
ModernaTX, Inc. |
VACCINE AGAINST THE HUMAN CYTOMEGALOVIRUS
|
|
SG11201803360UA
(en)
|
2015-10-22 |
2018-05-30 |
Modernatx Inc |
Nucleic acid vaccines for varicella zoster virus (vzv)
|
|
MA45209A
(fr)
|
2015-10-22 |
2019-04-17 |
Modernatx Inc |
Vaccins contre les maladies sexuellement transmissibles
|
|
EP3364949A4
(en)
|
2015-10-22 |
2019-07-31 |
ModernaTX, Inc. |
CANCER VACCINES
|
|
WO2017070624A1
(en)
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Tropical disease vaccines
|
|
DK3386484T3
(da)
|
2015-12-10 |
2022-07-04 |
Modernatx Inc |
Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler
|
|
US10465190B1
(en)
|
2015-12-23 |
2019-11-05 |
Modernatx, Inc. |
In vitro transcription methods and constructs
|
|
IL280430B2
(en)
|
2016-03-18 |
2023-11-01 |
Univ Texas |
Cyclic dinucleotide compounds and methods of use
|
|
EP4487869A3
(en)
*
|
2016-04-22 |
2025-07-30 |
CureVac SE |
Rna encoding a tumor antigen
|
|
US12128113B2
(en)
|
2016-05-18 |
2024-10-29 |
Modernatx, Inc. |
Polynucleotides encoding JAGGED1 for the treatment of Alagille syndrome
|
|
CN115837014A
(zh)
|
2016-05-18 |
2023-03-24 |
摩登纳特斯有限公司 |
编码松弛素的多核苷酸
|
|
SG11201901941YA
(en)
|
2016-09-14 |
2019-04-29 |
Modernatx Inc |
High purity rna compositions and methods for preparation thereof
|
|
EP3528821A4
(en)
|
2016-10-21 |
2020-07-01 |
ModernaTX, Inc. |
HUMAN CYTOMEGALOVIRUS VACCINE
|
|
MA46766A
(fr)
|
2016-11-11 |
2019-09-18 |
Modernatx Inc |
Vaccin antigrippal
|
|
EP3551193A4
(en)
|
2016-12-08 |
2020-08-19 |
Modernatx, Inc. |
NUCLEIC ACID VACCINES AGAINST RESPIRATORY VIRUSES
|
|
EP3555289A1
(en)
|
2016-12-13 |
2019-10-23 |
ModernaTX, Inc. |
Rna affinity purification
|
|
WO2018148381A1
(en)
*
|
2017-02-07 |
2018-08-16 |
Nantcell, Inc. |
Maximizing t-cell memory and compositions and methods therefor
|
|
MA47515A
(fr)
|
2017-02-16 |
2019-12-25 |
Modernatx Inc |
Compositions immunogènes très puissantes
|
|
WO2018170270A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Varicella zoster virus (vzv) vaccine
|
|
WO2018170256A1
(en)
*
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Herpes simplex virus vaccine
|
|
WO2018170260A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Respiratory syncytial virus vaccine
|
|
US11576961B2
(en)
|
2017-03-15 |
2023-02-14 |
Modernatx, Inc. |
Broad spectrum influenza virus vaccine
|
|
WO2018170347A1
(en)
|
2017-03-17 |
2018-09-20 |
Modernatx, Inc. |
Zoonotic disease rna vaccines
|
|
MA48047A
(fr)
|
2017-04-05 |
2020-02-12 |
Modernatx Inc |
Réduction ou élimination de réponses immunitaires à des protéines thérapeutiques administrées par voie non intraveineuse, par exemple par voie sous-cutanée
|
|
MA49421A
(fr)
|
2017-06-15 |
2020-04-22 |
Modernatx Inc |
Formulations d'arn
|
|
EP3668977A4
(en)
|
2017-08-18 |
2021-04-21 |
Modernatx, Inc. |
HPLC ANALYTICAL PROCESSES
|
|
WO2019036685A1
(en)
|
2017-08-18 |
2019-02-21 |
Modernatx, Inc. |
METHODS FOR HPLC ANALYSIS
|
|
WO2019036682A1
(en)
|
2017-08-18 |
2019-02-21 |
Modernatx, Inc. |
RNA VARIANTS POLYMERASE
|
|
MX2020002348A
(es)
|
2017-08-31 |
2020-10-08 |
Modernatx Inc |
Métodos de elaboración de nanopartículas lipídicas.
|
|
EP3681514A4
(en)
|
2017-09-14 |
2021-07-14 |
ModernaTX, Inc. |
RNA VACZINE AGAINST ZIKA VIRUS
|
|
US11911453B2
(en)
|
2018-01-29 |
2024-02-27 |
Modernatx, Inc. |
RSV RNA vaccines
|
|
US12528848B2
(en)
*
|
2018-05-25 |
2026-01-20 |
The Wistar Institute Of Anatomy And Biology |
Tumor-specific neoantigens and methods of using the same
|
|
US20210268086A1
(en)
*
|
2018-06-27 |
2021-09-02 |
Modernatx, Inc. |
Personalized cancer vaccine epitope selection
|
|
EP3827262A1
(en)
|
2018-07-26 |
2021-06-02 |
Frame Pharmaceuticals B.V. |
Cancer vaccines for breast cancer
|
|
WO2020022897A1
(en)
|
2018-07-26 |
2020-01-30 |
Frame Pharmaceuticals B.V. |
Method of preparing subject-specific immunogenic compositions based on a neo open-reading-frame peptide database
|
|
CN112996854B
(zh)
|
2018-09-19 |
2024-08-30 |
摩登纳特斯有限公司 |
高纯度peg脂质和其用途
|
|
US12151029B2
(en)
|
2018-09-19 |
2024-11-26 |
Modernatx, Inc. |
PEG lipids and uses thereof
|
|
US12090235B2
(en)
|
2018-09-20 |
2024-09-17 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
CN119978090A
(zh)
|
2018-10-19 |
2025-05-13 |
弗朗西斯·克里克研究所有限公司 |
新的癌抗原和方法
|
|
MA54192A
(fr)
*
|
2018-11-07 |
2021-09-15 |
Modernatx Inc |
Vaccins à arn contre le cancer
|
|
TWI852977B
(zh)
|
2019-01-10 |
2024-08-21 |
美商健生生物科技公司 |
前列腺新抗原及其用途
|
|
CN115120716A
(zh)
*
|
2019-01-14 |
2022-09-30 |
健泰科生物技术公司 |
用pd-1轴结合拮抗剂和rna疫苗治疗癌症的方法
|
|
CN113939282A
(zh)
|
2019-01-31 |
2022-01-14 |
摩登纳特斯有限公司 |
制备脂质纳米颗粒的方法
|
|
US11351242B1
(en)
|
2019-02-12 |
2022-06-07 |
Modernatx, Inc. |
HMPV/hPIV3 mRNA vaccine composition
|
|
US11851694B1
(en)
|
2019-02-20 |
2023-12-26 |
Modernatx, Inc. |
High fidelity in vitro transcription
|
|
MX2021010075A
(es)
|
2019-02-20 |
2021-12-10 |
Modernatx Inc |
Variantes de arn polimerasa para la formacion de casquetes cotranscripcionales.
|
|
CA3131824A1
(en)
*
|
2019-03-11 |
2020-09-17 |
Birgitte Rono |
Nucleic acid vaccination using neo-epitope encoding constructs
|
|
MX2021011031A
(es)
|
2019-03-11 |
2021-12-10 |
Modernatx Inc |
Proceso de transcripción in vitro en lotes alimentados.
|
|
MA55321A
(fr)
|
2019-03-15 |
2022-01-19 |
Modernatx Inc |
Vaccins à base d'arn contre le vih
|
|
CN114423449A
(zh)
*
|
2019-03-25 |
2022-04-29 |
俄亥俄州国家创新基金会 |
联合免疫调节及其用途
|
|
EP3962521A1
(en)
*
|
2019-05-02 |
2022-03-09 |
University of Florida Research Foundation, Inc. |
Compositions for treatment of diffuse intrinsic pontine glioma
|
|
JP2022535006A
(ja)
*
|
2019-05-31 |
2022-08-04 |
モデルナティエックス インコーポレイテッド |
増殖ｔ細胞アッセイ
|
|
CA3142404A1
(en)
*
|
2019-06-07 |
2020-12-10 |
Emory University |
Kras g12v mutant binds to jak1, inhibitors, pharmaceutical compositions, and methods related thereto
|
|
CN110172480B
(zh)
*
|
2019-06-11 |
2020-01-07 |
北京鼎成肽源生物技术有限公司 |
双抗原表位融合基因重组慢病毒载体、抗原提呈细胞和ctl细胞及其构建方法和应用
|
|
CN110172089B
(zh)
*
|
2019-06-11 |
2020-01-07 |
北京鼎成肽源生物技术有限公司 |
一种kras突变多抗原组合、靶向kras突变肿瘤ctl及其应用
|
|
EP3994156A1
(en)
|
2019-07-05 |
2022-05-11 |
The Francis Crick Institute Limited |
Novel cancer antigens and methods
|
|
JP2022546417A
(ja)
*
|
2019-08-29 |
2022-11-04 |
チューリッヒ大学 |
最小ｍＲＮＡおよびその使用
|
|
EP4061405A1
(en)
|
2019-11-18 |
2022-09-28 |
Janssen Biotech, Inc. |
Vaccines based on mutant calr and jak2 and their uses
|
|
WO2021119418A1
(en)
*
|
2019-12-11 |
2021-06-17 |
Vanderbilt University |
Methods of synthesizing mrna and functional proteins from synthetic double stranded dna
|
|
EP4096720A2
(en)
*
|
2020-01-30 |
2022-12-07 |
ModernaTX, Inc. |
Mrnas encoding metabolic reprogramming polypeptides and uses thereof
|
|
BR112022015077A2
(pt)
*
|
2020-01-31 |
2022-10-04 |
Genentech Inc |
Métodos para induzir células t cd8+ específicas de neoepítopos em um indivíduo com um tumor e para induzir o tráfico de células t cd8+, vacinas de rna, vacina de rna para uso e antagonistas de ligação
|
|
US20230096704A1
(en)
*
|
2020-02-05 |
2023-03-30 |
University Of Florida Research Foundation, Incorporated |
Rna-loaded nanoparticles and use thereof for the treatment of cancer
|
|
CN115461323A
(zh)
|
2020-03-11 |
2022-12-09 |
艾德凡斯化学公司 |
用于农用产品的表面活性剂
|
|
KR102701635B1
(ko)
|
2020-03-11 |
2024-08-30 |
어드밴식스 레진즈 앤드 케미컬즈 엘엘씨 |
오일 및 가스 생산을 위한 계면활성제
|
|
KR102924306B1
(ko)
*
|
2020-03-11 |
2026-02-09 |
어드밴식스 레진즈 앤드 케미컬즈 엘엘씨 |
건강관리 제품을 위한 계면활성제
|
|
EP4136096A1
(en)
*
|
2020-04-17 |
2023-02-22 |
The Francis Crick Institute Limited |
Antigen pool
|
|
CN118490818A
(zh)
|
2020-04-22 |
2024-08-16 |
生物技术欧洲股份公司 |
冠状病毒疫苗
|
|
US11130787B2
(en)
*
|
2020-06-11 |
2021-09-28 |
MBF Therapeutics, Inc. |
Alphaherpesvirus glycoprotein d-encoding nucleic acid constructs and methods
|
|
WO2022006368A2
(en)
|
2020-07-02 |
2022-01-06 |
Life Technologies Corporation |
Trinucleotide cap analogs, preparation and uses thereof
|
|
WO2022009049A1
(en)
|
2020-07-06 |
2022-01-13 |
Janssen Biotech, Inc. |
Prostate neoantigens and their uses
|
|
EP4175664A2
(en)
|
2020-07-06 |
2023-05-10 |
Janssen Biotech, Inc. |
Prostate neoantigens and their uses
|
|
WO2022031021A1
(ko)
*
|
2020-08-04 |
2022-02-10 |
성균관대학교산학협력단 |
동력학적 제어가 가능한 아주번트를 포함하는 mrna 백신
|
|
JP2023539454A
(ja)
|
2020-08-12 |
2023-09-14 |
アクティム・セラピューティクス・インコーポレイテッド |
免疫刺激細菌ベースのワクチン、治療薬およびｒｎａデリバリープラットフォーム
|
|
US11406703B2
(en)
|
2020-08-25 |
2022-08-09 |
Modernatx, Inc. |
Human cytomegalovirus vaccine
|
|
CA3198727A1
(en)
|
2020-10-20 |
2022-04-28 |
St Pharm Co., Ltd. |
Oligonucleotide for 5'-capped rna synthesis
|
|
WO2022087424A1
(en)
*
|
2020-10-22 |
2022-04-28 |
The Regents Of The University Of California |
Monoamine oxidase blockade therapy for treating cancer through regulating tumor associated macrophages (tams)
|
|
US20240011033A1
(en)
*
|
2020-11-04 |
2024-01-11 |
Boehringer Ingelheim International Gmbh |
Viral vectors and nucleic acids for use in the treatment of ild, pf-ild and ipf
|
|
WO2022120560A1
(zh)
*
|
2020-12-08 |
2022-06-16 |
深圳市瑞吉生物科技有限公司 |
一种mRNA剂型的免疫抑制剂及其在制备肿瘤治疗药物中的应用
|
|
US20240299516A1
(en)
*
|
2020-12-21 |
2024-09-12 |
University Of Florida Research Foundaton, Inc. |
Multilamellar rna nanoparticle vaccine against cancer
|
|
CN114717229B
(zh)
*
|
2021-01-05 |
2024-09-10 |
麦塞拿治疗(香港)有限公司 |
治疗性mRNA的无细胞和无载体体外RNA转录方法和核酸分子
|
|
WO2022150717A1
(en)
|
2021-01-11 |
2022-07-14 |
Modernatx, Inc. |
Seasonal rna influenza virus vaccines
|
|
AU2022221309A1
(en)
*
|
2021-02-09 |
2023-08-24 |
Virginia Commonwealth University |
Mini circular rna therapeutics and vaccines and methods of use thereof
|
|
US11524023B2
(en)
|
2021-02-19 |
2022-12-13 |
Modernatx, Inc. |
Lipid nanoparticle compositions and methods of formulating the same
|
|
US20240181030A1
(en)
*
|
2021-03-26 |
2024-06-06 |
Modernatx, Inc. |
Pertussis vaccine
|
|
NL2028681B1
(en)
*
|
2021-04-02 |
2022-10-17 |
Nutcracker Therapeutics Inc |
Materials and methods for generating antigen-specific t cells and treating diseases
|
|
EP4326227A1
(en)
|
2021-04-23 |
2024-02-28 |
ModernaTX, Inc. |
Stabilized formulations
|
|
CN113186285B
(zh)
*
|
2021-05-10 |
2022-05-24 |
深圳市展行生物有限公司 |
一种辅助诊断胃癌的方法及其使用的miRNA组合
|
|
US20220363937A1
(en)
|
2021-05-14 |
2022-11-17 |
Armstrong World Industries, Inc. |
Stabilization of antimicrobial coatings
|
|
CN113577258B
(zh)
*
|
2021-07-31 |
2024-04-16 |
山东兴瑞生物科技有限公司 |
一种双靶点mRNA疫苗及其制备方法
|
|
CN115703714B
(zh)
*
|
2021-08-13 |
2025-06-10 |
广州谷森制药有限公司 |
阳离子脂质化合物
|
|
WO2023030635A1
(en)
*
|
2021-09-02 |
2023-03-09 |
BioNTech SE |
Potency assay for therapeutic potential of coding nucleic acid
|
|
CA3230564A1
(en)
|
2021-09-13 |
2023-03-16 |
Jean-Pol DETIFFE |
Method to generate personalized neoantigens of a tumor of a patient
|
|
EP4147713A1
(en)
*
|
2021-09-13 |
2023-03-15 |
OncoDNA |
A rna vaccine comprising an rna pool generated from a double-stranded dna pool
|
|
EP4147712A1
(en)
|
2021-09-13 |
2023-03-15 |
OncoDNA |
Method to generate a double-stranded dna pool encoding neoantigens of a tumor of a patient
|
|
WO2023086796A2
(en)
|
2021-11-09 |
2023-05-19 |
Actym Therapeutics, Inc. |
Immunostimulatory bacteria for converting macrophages into a phenotype amenable to treatment, and companion diagnostic for identifying subjects for treatment
|
|
US12186387B2
(en)
|
2021-11-29 |
2025-01-07 |
BioNTech SE |
Coronavirus vaccine
|
|
US12529047B1
(en)
|
2021-12-21 |
2026-01-20 |
Modernatx, Inc. |
mRNA quantification methods
|
|
WO2023125974A1
(zh)
*
|
2021-12-31 |
2023-07-06 |
广州国家实验室 |
mRNA疫苗
|
|
US11878055B1
(en)
|
2022-06-26 |
2024-01-23 |
BioNTech SE |
Coronavirus vaccine
|
|
CA3262766A1
(en)
*
|
2022-07-28 |
2024-02-01 |
Stemcell Technologies Canada Inc. |
Polynucleotides encoding bound antigens and their uses
|
|
CN119286892A
(zh)
*
|
2022-09-22 |
2025-01-10 |
浙江大学医学院附属第一医院(浙江省第一医院) |
一种重组mRNA、DNA分子、药物组合物、疫苗及制备方法
|
|
AU2023357899A1
(en)
*
|
2022-10-07 |
2025-05-01 |
University Of Tsukuba |
Design method and production method for nucleic acid construct and protein complex
|
|
EP4604981A2
(en)
*
|
2022-10-19 |
2025-08-27 |
KaliVir Immunotherapeutics, Inc. |
Nucleic acids encoding soluble pd-1 and il-12 and uses thereof
|
|
JP2026502789A
(ja)
*
|
2022-10-31 |
2026-01-27 |
グリットストーン バイオ インコーポレイテッド |
組み合わせパネルのセルフリーｄｎａモニタリング
|
|
US20260176618A1
(en)
*
|
2022-11-03 |
2026-06-25 |
Modernatx, Inc. |
Chemical stability of mrna
|
|
EP4364752A1
(en)
|
2022-11-07 |
2024-05-08 |
OncoDNA |
Improved vaccine
|
|
CN116970614A
(zh)
*
|
2022-12-29 |
2023-10-31 |
达冕疫苗(广州)有限公司 |
编码ny-eso-1的核糖核酸疫苗的组合物和方法
|
|
WO2024153000A1
(en)
*
|
2023-01-17 |
2024-07-25 |
The University Of Hong Kong |
Cancer immunotherapy by delivery of mrna
|
|
CN116585342B
(zh)
*
|
2023-05-23 |
2024-08-16 |
源生生物科技(青岛)有限责任公司 |
包含miRNA的活性成分及其应用
|
|
WO2025054383A1
(en)
*
|
2023-09-06 |
2025-03-13 |
Modernatx, Inc. |
Chemical stability of mrna
|
|
WO2025080869A1
(en)
*
|
2023-10-11 |
2025-04-17 |
The Regents Of The University Of California |
Pancreatic cancer immunotherapy using cationic lipid and polymer nanocarriers for co-delivery of kras neoantigens and sting and/or other immunomodulators to boost the cancer immunity cycle and treat liver metastasis
|
|
WO2025117816A1
(en)
*
|
2023-12-01 |
2025-06-05 |
Recode Therapeutics, Inc. |
Lipid nanoparticle compositions and uses thereof
|
|
CN121464216A
(zh)
*
|
2024-01-17 |
2026-02-03 |
艾博生物科技(上海)有限公司 |
用于诱导针对kras突变细胞的抗原特异性免疫的组合物和方法
|
|
WO2025158069A1
(en)
*
|
2024-01-25 |
2025-07-31 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
CONSTRUCT COMPRISING mRNA-STRAND AND RETINOIC ACID-INDUCIBLE GENE I (RIG-I)-LIGAND(S), PHARMACEUTICAL COMPOSITION AND KIT COMPRISING THE SAME
|
|
CN118389553A
(zh)
*
|
2024-03-01 |
2024-07-26 |
中国科学技术大学 |
免疫增效rna分子及其组合物、疫苗与试剂盒
|
|
CN117883558B
(zh)
*
|
2024-03-15 |
2024-06-14 |
山东兴瑞生物科技有限公司 |
靶向肝肿瘤个性化mRNA疫苗的制备方法
|
|
WO2025235990A1
(en)
*
|
2024-05-10 |
2025-11-13 |
Metrohealth Ventures Llc |
Cancer oncogene mrna vaccine
|
|
WO2026005647A2
(ru)
*
|
2024-06-29 |
2026-01-02 |
федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации |
Иммунобиологическое средство для терапии онкологических заболеваний на основе мрнк вектора
|
|
WO2026005646A2
(ru)
*
|
2024-06-29 |
2026-01-02 |
федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации |
Способ формирования системы иммунного надзора за опухолевыми клетками в организме млекопитающих
|
|
CN119874872B
(zh)
*
|
2025-01-17 |
2025-11-25 |
武汉大学 |
一种mita铰链区突变多肽及其在自身免疫性疾病中的应用
|